Public Company News

LG Innotek Develops the World's First Automotive Wi-Fi 6E Module

* Automotive-qualified near-field, wireless communication components based on Wi-Fi 6E * Improved communication performance, durability, and applicability * "LG Innotek will accelerate the evolution of in-vehicle infotainment" SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- LG Innotek (CEO...

2021-03-03 17:00 2402

Polygiene adds value to brand Descente, part of Anta Sports Products group's extensive portfolio

STOCKHOLM, March 3, 2021 /PRNewswire/ -- For the spring and summer season 2021, a number of Descente training products for men and women, with Polygiene® Stays Fresh BioStatic Technology, will be sold online and in stores. With these initial orders, the focus is set for ongoing business and incre...

2021-03-03 16:08 2303

Nexteer Expands Driveline Portfolio for Electric Vehicles

* Seven Technologies Tailored to Unique Demands of EVs * Enhances Durability, Efficiency & Optimizes NVH Performance AUBURN HILLS, Mich., March 3, 2021 /PRNewswire/ -- Nexteer Automotive , a leader in intuitive motion control, continues expanding its Dri...

2021-03-03 13:39 4003

"Small Yet Powerful", New Shai Class to Arrive in Black Desert Mobile

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Pearl Abyss announced today that a brand-new class "Shai" will be making her way toBlack Desert Mobile on March 23. This new class will be the perfect choice for Adventurers who like to engage in battles and exploration. 

2021-03-03 10:00 2688

LG Innotek Develops the World's First Automotive Wi-Fi 6E Module

* Automotive-qualified near-field, wireless communication components based on Wi-Fi 6E * Improved communication performance, durability, and applicability * "LG Innotek will accelerate the evolution of in-vehicle infotainment" SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- LG Innotek (CEO...

2021-03-03 10:00 3982

Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

* Seegene's new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 minutes * Seegene's proprietary high multiplex technology enables detection of 10 different targets * S. Korean firm to research additional versions of variant diagnostic tests SEOUL, South Korea,...

2021-03-03 09:20 1976

EZZ Life Science Holdings Limited to list on the ASX today following oversubscribed A$6m IPO

SYDNEY, March 3, 2021 /PRNewswire/ -- Australian beauty and wellness product company, EZZ Life Science Holdings Limited is set to list on the Australian Securities Exchange (ASX) today after raisingA$6 million through its successful and oversubscribed Initial Public Offer. EZZ shares are due to ...

2021-03-03 07:52 8895

Roaring Debut for the Reaper of Death as it Dominates The Royal Canadian Mint's Latest Collector Coin Offering

OTTAWA, ON, March 3, 2021 /PRNewswire/ -- Greek for "Reaper of Death", the Thanatotheristes degrootorum is a fascinating find for Canada: the first new tyrannosaur species to be discovered in the country in over 50 years. Paleoartist Julius Csotonyi, who was the first to ever illustrate the fears...

2021-03-03 04:05 4081

Artmarket.com: the Artprice100© index is continuing to grow... +405% since 2000

PARIS, March 2, 2021 /PRNewswire/ -- Artprice's blue-chip artists index, the Artprice100©, actually grew by 1.8% over the past year… a year marked by the almost complete absence of international fairs, but also by the forced transition of galleries and auction houses to a digitalmodus operandi. A...

2021-03-02 22:05 9660

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 6189

Glory Star Develops In-Vehicle Interactive Content Application for New Energy Vehicles

BEIJING, March 2, 2021 /PRNewswire/ -- Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) ("Glory Star" or the "Company"), a leading mobile and online digital media and entertainment company inChina, today announced that its independently developed in-vehicle audio and video interactive c...

2021-03-02 21:00 4629

Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal

HONG KONG, March 2, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors (the "...

2021-03-02 20:00 11198

Proofpoint Commended by Frost & Sullivan for Leading the Australian Market with Pioneering Email Security Innovations

Expansive functions and interoperability with third-party systems deliver flexibility and scalability to enterprises of all sizes SINGAPORE, March 2, 2021 /PRNewswire/ -- Based on its recent analysis of the email security market, Frost & Sullivan recognizesProofpoint, Inc. with the 2020 Australi...

2021-03-02 19:41 3914

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg)

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug...

2021-03-02 16:01 5239

Marriott International Pilots AI Solutions to Streamline Hotel Design Process for Future Properties in Asia-Pacific

HONG KONG, March. 2, 2021 /PRNewswire/ -- Marriott International Inc. (NASDAQ: MAR) is reinventing how hotels in its Select Service brand portfolio are designed and constructed using a suite of proprietary solution. A first to be piloted inAsia Pacific, Marriott's end-to-end, one-stop solution is...

2021-03-02 14:00 6562

XCMG Sends Off 400 Units of Flagship Products to Countries of the Belt and Road Initiative

XUZHOU, China, March 2, 2021 /PRNewswire/ -- Leading construction machinery manufacturer XCMG (000425.SZ) has sailed off more than 400 units of construction machinery equipment onFebruary 18 from China, which will be arriving in countries of the Belt and Road Initiative (BRI) including Southeast ...

2021-03-02 13:37 5203

ZTE ranks global top 3 for sustainable leadership in 5G declared Standard-Essential Patents to ETSI

SHENZHEN, China, March 2, 2021 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, has been included global top 3 for its sustainable leadership in 5G declared Standard-E...

2021-03-02 12:38 6569

Vestiaire Collective announces a new €178m (US$ 216m) financing round backed by Kering and Tiger Global Management

PARIS, March 2, 2021 /PRNewswire/ -- The leading global platform for desirable second-hand fashion today announces the completion of a new €178 million financing round, backed by global French luxury group Kering (KER.PA) and US investment firm Tiger Global Management. Existing shareholders inclu...

2021-03-02 11:17 3283

Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB

SYDNEY, March 2, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM), an innovation-focuse...

2021-03-02 07:00 4915

INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18

Trial achieved primary and secondary efficacy endpoints among all evaluable subjects in the Phase 3 multi-center, randomized, double-blind, placebo-controlled trial VGX-3100 is the first DNA medicine to achieve efficacy endpoints in a Phase 3 clinical trial INOVIO also continues to partner with...

2021-03-02 05:05 5510
1 ... 855856857858859860861 ... 891

Week's Top Stories